Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

AUSTRIA: NEW ENGINES BY BOMBARDIER-ROTAX

Article Abstract:

Austrian Gunskirchen-based Bombardier-Rotax Gesellschaft m.b.H. has earmarked Sch 1.5bn for the development of new engines in the next five years. The subsidiary of Bombardier Inc. of Canada is thus doubling the spending. Beside further 2-stroke engines, Bombardier-Rotax is to develop 4-stroke engines for Bombardier Recreational Products such as snowmobiles, ski slope preparation vehicles, pleasure boats and all-purpose buggies. Key objects in the development of the engines is the reduction of emissions, noise and fuel consumption. Where the new engines will be produced will be decided in spring 2000. Series production is to start by the end of the year. In 1998 Bombardier-Rotax made a profit on ordinary activities of Sch 105mn. The entire Bombardier Recreational Products division made a loss of about Sch 411mn.

Publisher: Unabhaengige Tageszeitungs fuer Oesterreich
Publication Name: Presse
Subject: Business, international
ISSN:
Year: 1999
Product development, Air-Conditioning and Warm Air Heating Equipment and Commercial and Industrial Refrigeration Equipment Manufacturing, All Other Transportation Equipment Manufacturing, Other Engine Equipment Manufacturing, Outboard Motors, Internal Combustion Engines, Snowmobiles, Snowmaking Machines, Bombardier-Rotax GmbH

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Austria: Baxter developing new vaccines

Article Abstract:

Austrian bio-technology firm Baxter is in the process of developing vaccines for Lyme disease, hepatitis A and influenza. The Lyme disease vaccine is still at the research phase. Lyme disease is a bacterial infection spread mainly, but not exclusively, by ticks, and there are an estimated 80,000 cases in Germany per year. The new influenza vaccine that is being developed is to be cultivated using mammal cells rather than chicken eggs, and the hepatitis A vaccine will also be cultivated using the same technology.

Publisher: Unabhaengige Tageszeitungs fuer Oesterreich
Publication Name: Presse
Subject: Business, international
ISSN:
Year: 2001
Vaccines & Antigens for Human Use, Biological Product (except Diagnostic) Manufacturing, Biological products exc. diagnostic, Biological products

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Austria
Similar abstracts:
  • Abstracts: AUSTRIA: MORE FOREIGN COMPANIES ENTER MARKET. Austria: Code of practice for companies. AUSTRIA: INCOMES FALLING IN AGRICULTURAL SECTOR
  • Abstracts: AUSTRIA: COMPENSATIONS FOR HOSPITAL PATIENTS. Austria: Safety measures to protect night time workers
  • Abstracts: AUSTRIA: COMPENSATIONS FOR HOSPITAL PATIENTS. Austria: Opposition to collective system reform
  • Abstracts: AUSTRIA: CAR DEALERS JOIN FORCES IN INTERNET. New partnership to the rescue. Pets.com
  • Abstracts: AUSTRIA: CAPITAL INJECTION TO WINTERSTEIGER. Schelling auf Erfolgskurs
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.